Novavax Inc said on Tuesday its experimental COVID19 vaccine produced high levels of antibodies against the novel coronavirus, according to initial data from a small, earlystage clinical trial, sending the company's shares up 10%. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: